Pfizer Has Eyes On EU Rituximab Market Following EC Approval

Ruxience Approved For All Indications Of Reference Brand

EU_White_Arrow
Pfizer can begin preparations to roll out rituximab in Europe. • Source: Shutterstock

More from Biosimilars

More from Products